Bamco Inc /Ny/
Source: SEC Form 13F · as of Mar 2026Bamco Inc /Ny/ holds 16 biotech & pharma companies tracked by BioSniper, totaling $169.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$169.9M
BioSniper AIPage context preserved
Prepared research question
What matters most for ARGENX SE (ARGX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ARGXARGENX SE | 138,648 | $101.2M |
| ARQTArcutis Biotherapeutics, Inc. | 1,072,189 | $25.3M |
| SPRYARS Pharmaceuticals, Inc. | 1,273,341 | $10.2M |
| GILDGILEAD SCIENCES, INC. | 30,000 | $4.2M |
| VKTXViking Therapeutics, Inc. | 125,486 | $4.1M |
| TEVATeva Pharmaceutical Industries Limited | 130,000 | $3.9M |
| MANEVeradermics Incorporated | 59,668 | $3.8M |
| ROIVRoivant Sciences Ltd. | 125,000 | $3.5M |
| IONSIONIS PHARMACEUTICALS INC | 45,000 | $3.4M |
| INSMINSMED Inc | 20,000 | $3.3M |
| TERNTerns Pharmaceuticals, Inc. | 35,000 | $1.8M |
| PTGXProtagonist Therapeutics, Inc | 15,000 | $1.6M |
| CYTKCYTOKINETICS INC | 23,000 | $1.5M |
| APGEApogee Therapeutics, Inc. | 15,000 | $1.3M |
| ABVXAbivax SA | 5,500 | $612K |
| RVMDREVOLUTION MEDICINES, INC. | 2,500 | $243K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.